Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome

NARecruitingINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

December 5, 2019

Primary Completion Date

June 30, 2024

Study Completion Date

September 30, 2024

Conditions
Reversible Cerebral Vasoconstriction Syndrome
Interventions
OTHER

Constitution of a biobank

"We are collecting additional blood and CSF samples for patients (during RCVS episode and after resolution of RCVS episode) and for control subjects to constitute a biobank, in order to compare different biologic parameters between RCVS patients and healthy volunteers. A specific agreement will be asked to patients and control subjects before collection of samples.~This is why this study is classified as 'interventional' rather than 'observational'."

Trial Locations (1)

34295

RECRUITING

Gui de Chauliac Hospital, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER